logo

For the Inventor, By the Inventor

Gaithersburg, MD, United States of America

Christine Fazenbaker

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Pharmaceuticals LP. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Fazenbaker. Retrieved from https://idiyas.com/inventor/christine-fazenbaker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 40 
 
Astrazeneca Pharmaceuticals LP
 patents

Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents
1. 12686707 - ANTI-STEAP2 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF (2026-07-21),

Title: Christine Fazenbaker: Patent Activity in Biotechnology

Introduction

Christine Fazenbaker is an inventor associated with Gaithersburg, Maryland, and AstraZeneca Pharmaceuticals LP. Her patent activity includes work on a chimeric antigen receptor targeting STEAP2.

Latest Patents

Fazenbaker is listed on one patent: “Anti-STEAP2 Chimeric Antigen Receptors and Uses Thereof.” The invention concerns engineered receptors and their potential uses.

Career Highlights

Fazenbaker’s recorded patent work reflects participation in biotechnology research and development at AstraZeneca Pharmaceuticals LP. Her listed portfolio includes 1 patent.

Collaborations

The patent lists Gordon Moody and Chien-Ying Chang among Fazenbaker’s collaborators.

Conclusion

Christine Fazenbaker’s patent record highlights her contribution to research involving STEAP2-targeting chimeric antigen receptors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…